-
Post date
May 12, 2022
-
Posted by
Kieran Robertson
-
Posted in
best psychedelic companies, clinical psychedelics, clinical trials psilocybin 2021, cmps.q, COMPASS, Filament, Filament Health, Filament Health (FH.NE), filament health clinical trials, filament health ipo, Filament Health Natural Psychedelic, filament health neo, Filament Health Trials, filament stock, medical psychedelics, Mind Medicine Inc., MindMEd, mmed.ne, Mushrooms, Natural psilocybin extraction, naturally extracted psilocybin, pharmaceutical grade psilocybin, Psilo Scientific, psilocybin, psilocybin based therapies, psilocybin clinical trials, psilocybin market, psilocybin mushrooms, psilocybin studies, psilocybin studies 2022, Psychedelics, Today's Idea
-
Post date
March 28, 2022
-
Posted by
Kieran Robertson
-
Posted in
clinical trials shroom stocks, FH.NE, Filament, Filament Health, Filament Health (FH.NE), filament health clinical trials, Filament Health Natural Psychedelic, Filament Health Trials, filament stock, Major depressive disorder, MDD, mental health, mental health issues, mushroom, mushroom formulation, mushroom growing kit, mushroom hat, mushroom market, mushroom markets, mushroom research, mushroom stocks, Mushrooms, organic mushrooms, psilocybin mushrooms, Psychedelics, shrooms, spent mushroom compost, Today's Idea
-
Post date
March 28, 2022
-
Posted by
Kieran Robertson
-
Posted in
clinical trials shroom stocks, FH.NE, Filament, Filament Health, Filament Health (FH.NE), filament health clinical trials, Filament Health Natural Psychedelic, Filament Health Trials, filament stock, Major depressive disorder, MDD, mental health, mental health issues, mushroom, mushroom formulation, mushroom growing kit, mushroom hat, mushroom market, mushroom markets, mushroom research, mushroom stocks, Mushrooms, organic mushrooms, psilocybin mushrooms, Psychedelics, Series, shrooms, spent mushroom compost, Today's Idea
-
Post date
March 18, 2022
-
Posted by
Kieran Robertson
-
Posted in
best psychedelics companies, best psychedelics stocks, Canadian psychedelics companies, Canadian psychedelics market, clinical trials psychedelics, Dealer's License, Health Canada approval, licensed dealer, medical psychedelics, mushroom, mushroom formulation, mushroom laws, mushroom legalization, mushroom market, mushroom markets, mushroom research, mushroom stocks, Mushrooms, natural psychedelics, OPTI.C, Optimi, Optimi Health, Optimi Health Corp., psilocybin mushrooms, Psychedelics, psychedelics stocks 2022
-
Post date
March 18, 2022
-
Posted by
Kieran Robertson
-
Posted in
best psychedelics companies, best psychedelics stocks, Canadian psychedelics companies, Canadian psychedelics market, clinical trials psychedelics, Dealer's License, Health Canada approval, licensed dealer, medical psychedelics, mushroom, mushroom formulation, mushroom laws, mushroom legalization, mushroom market, mushroom markets, mushroom research, mushroom stocks, Mushrooms, natural psychedelics, OPTI.C, Optimi, Optimi Health, Optimi Health Corp., psilocybin mushrooms, Psychedelics, psychedelics stocks 2022